Privia Health Group (PRVA) News Today $22.24 +0.39 (+1.78%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period JPMorgan Chase & Co. Has $3.43 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)JPMorgan Chase & Co. grew its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 8.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 188,384 shares of the company's stock after purchasing an additional 14,641January 19 at 3:04 AM | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Siemens Healthineers AG (SEMHF), Privia Health Group (PRVA)January 16, 2025 | markets.businessinsider.comPrivia Health Group (PRVA) Receives a Buy from Evercore ISIJanuary 16, 2025 | markets.businessinsider.comVsee Health (NASDAQ:VSEE) and Privia Health Group (NASDAQ:PRVA) Financial ComparisonJanuary 16, 2025 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Coverage Initiated at Needham & Company LLCJanuary 13, 2025 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Consensus Price Target from AnalystsJanuary 11, 2025 | americanbankingnews.comNeedham Initiates Coverage of Privia Health Group (PRVA) with Buy RecommendationJanuary 10, 2025 | msn.comPrivia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLCNeedham & Company LLC began coverage on Privia Health Group in a research report on Friday. They set a "buy" rating and a $25.00 target price for the company.January 10, 2025 | marketbeat.comNordea Investment Management AB Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA)Nordea Investment Management AB lifted its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 33.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 349,773 shares of the company's stock after acquiring aJanuary 10, 2025 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of "Buy" by BrokeragesPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has received an average rating of "Buy" from the seventeen research firms that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, thirteen have given aJanuary 8, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Privia Health Gr Through 6 AnalystsJanuary 2, 2025 | benzinga.comPrivia Health Group (NASDAQ:PRVA) Earns "Overweight" Rating from StephensStephens reiterated an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday.January 2, 2025 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Position Decreased by Principal Financial Group Inc.Principal Financial Group Inc. lowered its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,252,337 shares of the company's stock after sellinDecember 23, 2024 | marketbeat.comBarclays PLC Acquires 158,188 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Barclays PLC boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 240.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 224,018 shares of the company's stock after buying an additional 15December 23, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Franklin Resources Inc.Franklin Resources Inc. raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,300,240 shares of the company's stock afterDecember 20, 2024 | marketbeat.comState Street Corp Sells 39,008 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)State Street Corp cut its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 0.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,160,634 shares of the company's stock after selling 39,008 shares duDecember 18, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Trading Down 5.2% - Time to Sell?Privia Health Group (NASDAQ:PRVA) Trading Down 5.2% - What's Next?December 17, 2024 | marketbeat.comPrivia Health initiated with an Outperform at MacquarieDecember 17, 2024 | markets.businessinsider.comMacquarie Initiates Coverage of Privia Health Group (PRVA) with Outperform RecommendationDecember 17, 2024 | msn.comPrivia Health Group (NASDAQ:PRVA) Coverage Initiated by Analysts at MacquarieMacquarie began coverage on shares of Privia Health Group in a report on Monday. They set an "outperform" rating on the stock.December 16, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of "Buy" from BrokeragesPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has been assigned an average recommendation of "Buy" from the fifteen research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have assigneDecember 14, 2024 | marketbeat.comWellington Management Group LLP Sells 1,922,875 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Wellington Management Group LLP trimmed its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 35.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,513,588 shares of the company's stocDecember 11, 2024 | marketbeat.comPier Capital LLC Has $7.10 Million Position in Privia Health Group, Inc. (NASDAQ:PRVA)Pier Capital LLC lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 389,895 shares of the company's stock after buying an additional 84,786 shares during tDecember 8, 2024 | marketbeat.comHolocene Advisors LP Sells 79,819 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Holocene Advisors LP trimmed its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 77.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,799 shares of the company's stock after seDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 65,152 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Charles Schwab Investment Management Inc. boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 6.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,064,224 shares of the companDecember 7, 2024 | marketbeat.comSoros Fund Management LLC Raises Stake in Privia Health Group, Inc. (NASDAQ:PRVA)Soros Fund Management LLC lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 25.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 750,000 shares of the company's stock afterDecember 6, 2024 | marketbeat.comPrivia Health Group Insiders Placed Bullish Bets Worth US$9.31mDecember 6, 2024 | finance.yahoo.comBridgewater Associates LP Sells 45,829 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Bridgewater Associates LP cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 52.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,115 shares of the company's stock afterDecember 3, 2024 | marketbeat.com25,387 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Bought by Intech Investment Management LLCIntech Investment Management LLC bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 25,387 shares of the company's stock, valued at approximDecember 3, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Acquired by Fmr LLCFmr LLC boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 1.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 18,169,043 shares of the company's stock after purchasing an additional 271,645 shares duDecember 1, 2024 | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock PriceJPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research note on Friday.November 29, 2024 | marketbeat.comEventide Asset Management LLC Acquires 746,231 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Eventide Asset Management LLC raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 979.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 822,438 shares of the company's stock after buying an additional 746,231November 29, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Invests $1.21 Million in Privia Health Group, Inc. (NASDAQ:PRVA)Dynamic Technology Lab Private Ltd bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 66,192 shares of the company's stock, valued at approximately $1,206,000November 27, 2024 | marketbeat.comVictory Capital Management Inc. Raises Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)Victory Capital Management Inc. increased its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 402.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 179,049 shares ofNovember 24, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Icon Wealth Advisors LLCIcon Wealth Advisors LLC increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 1,910.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 300,889 shares of the compNovember 22, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of "Buy" from AnalystsShares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been given an average rating of "Buy" by the sixteen research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, twelve have issued a buy ratingNovember 19, 2024 | marketbeat.comGSA Capital Partners LLP Acquires 35,439 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)GSA Capital Partners LLP grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 228.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 50,975 shares of the company's stock after buying an additional 3November 16, 2024 | marketbeat.comPrivia Health Group: Strong Performance and Growth Potential Justifies Buy RatingNovember 13, 2024 | markets.businessinsider.comStifel Nicolaus Sticks to Its Buy Rating for Privia Health Group (PRVA)November 11, 2024 | markets.businessinsider.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. decreased its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,252,337 shares of the company's stock after selling 84November 10, 2024 | marketbeat.comPrivia Health Group Inc (PRVA) Q3 2024 Earnings Call Highlights: Strong Financial Performance ...November 9, 2024 | finance.yahoo.comPrivia Health Group, Inc. (PRVA) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comPrivia Health Group Reports Strong Q3 2024 ResultsNovember 8, 2024 | markets.businessinsider.comRBC Capital Sticks to Its Buy Rating for Privia Health Group (PRVA)November 8, 2024 | markets.businessinsider.comPrivia Health Group (NASDAQ:PRVA) Price Target Raised to $21.00Barclays lifted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a research report on Friday.November 8, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Given New $27.00 Price Target at Truist FinancialTruist Financial boosted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Friday.November 8, 2024 | marketbeat.comRobust Growth and Strategic Expansion Drive ‘Buy’ Rating for Privia Health GroupNovember 8, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Cross Country Healthcare (CCRN), CVS Health (CVS) and Privia Health Group (PRVA)November 7, 2024 | markets.businessinsider.comPrivia Health Group, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comPrivia Health Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.com Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVA Media Mentions By Week PRVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVA News Sentiment▼0.360.44▲Average Medical News Sentiment PRVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVA Articles This Week▼44▲PRVA Articles Average Week Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIMS News Today RDNT News Today OPCH News Today GH News Today SHC News Today VCYT News Today BTSG News Today LFST News Today SGRY News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRVA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
